West Pharmaceutical (WST)

[braden]

West Pharmaceutical beats Street 3Q forecasts


October 27, 2016






EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported third-quarter earnings of $37.6 million.
On a per-share basis, the Exton, Pennsylvania-based company said it had profit of 50 cents. Earnings, adjusted for restructuring costs and pretax expenses, were 53 cents per share.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 52 cents per share.
The medical device company posted revenue of $376.7 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $372.7 million.
West Pharmaceutical shares have climbed 17 percent since the beginning of the year. The stock has climbed 23 percent in the last 12 months.